Clinical Trial Update: Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Targretin (bexarotene) capsules for advanced or metastatic non-small cell lung cancer has completed, with results posted in August 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Targretin (bexarotene)

Snippet

Sponsor: Eisai Inc. | Conditions: Non-small Cell Lung Cancer | Phase 3 | Status: COMPLETED | Results posted: 2010-08-24